Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;14(5):285-300.
doi: 10.1038/nrendo.2018.22. Epub 2018 Mar 16.

Growth Hormone - Past, Present and Future

Affiliations
Review

Growth Hormone - Past, Present and Future

Michael B Ranke et al. Nat Rev Endocrinol. .

Abstract

Growth hormone (GH) research and its clinical application for the treatment of growth disorders span more than a century. During the first half of the 20th century, clinical observations and anatomical and biochemical studies formed the basis of the understanding of the structure of GH and its various metabolic effects in animals. The following period (1958-1985), during which pituitary-derived human GH was used, generated a wealth of information on the regulation and physiological role of GH - in conjunction with insulin-like growth factors (IGFs) - and its use in children with GH deficiency (GHD). The following era (1985 to present) of molecular genetics, recombinant technology and the generation of genetically modified biological systems has expanded our understanding of the regulation and role of the GH-IGF axis. Today, recombinant human GH is used for the treatment of GHD and various conditions of non-GHD short stature and catabolic states; however, safety concerns still accompany this therapeutic approach. In the future, new therapeutics based on various components of the GH-IGF axis might be developed to further improve the treatment of such disorders. In this Review, we describe the history of GH research and clinical use with a particular focus on disorders in childhood.

Similar articles

See all similar articles

Cited by 13 articles

See all "Cited by" articles

References

    1. Pediatr Res. 1996 Feb;39(2):295-302 - PubMed
    1. Growth Horm IGF Res. 2003 Aug;13(4):113-70 - PubMed
    1. Horm Res. 2009;71(5):276-84 - PubMed
    1. Eur J Endocrinol. 2016 Apr;174(4):R145-73 - PubMed
    1. Nat Genet. 1996 Jan;12(1):88-90 - PubMed

LinkOut - more resources

Feedback